- Form 8-K/A details executive leadership succession at Harmony Biosciences.
- COO Peter Anastasiou appointed President & CEO and Class I Director.
- Former CEO Jeffrey Dayno to provide advisory consulting services through January 2028.
? Neutral AI Sentiment (-0.5 / 10)